Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040.
Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016.
Mol Biol Cell. 2020 Apr 15;31(9):859-865. doi: 10.1091/mbc.E18-10-0668.
The efficient maintenance of genome integrity in the face of cellular stress is vital to protect against human diseases such as cancer. DNA replication, chromatin dynamics, cellular signaling, nuclear architecture, cell cycle checkpoints, and other cellular activities contribute to the delicate spatiotemporal control that cells utilize to regulate and maintain genome stability. This perspective will highlight DNA double-strand break (DSB) repair pathways in human cells, how DNA repair failures can lead to human disease, and how PARP inhibitors have emerged as a novel clinical therapy to treat homologous recombination-deficient tumors. We briefly discuss how failures in DNA repair produce a permissive genetic environment in which preneoplastic cells evolve to reach their full tumorigenic potential. Finally, we conclude that an in-depth understanding of DNA DSB repair pathways in human cells will lead to novel therapeutic strategies to treat cancer and potentially other human diseases.
面对细胞应激,高效地维持基因组完整性对于预防癌症等人类疾病至关重要。DNA 复制、染色质动力学、细胞信号转导、核结构、细胞周期检查点和其他细胞活动有助于细胞利用精细的时空控制来调节和维持基因组稳定性。本文观点将重点介绍人类细胞中的 DNA 双链断裂 (DSB) 修复途径,DNA 修复失败如何导致人类疾病,以及聚腺苷二磷酸核糖聚合酶 (PARP) 抑制剂如何成为治疗同源重组缺陷型肿瘤的新型临床疗法。我们简要讨论了 DNA 修复失败如何产生允许性遗传环境,使前期肿瘤细胞进化并充分发挥其致瘤潜能。最后,我们得出结论,深入了解人类细胞中的 DNA DSB 修复途径将为治疗癌症和其他人类疾病提供新的治疗策略。